EU regulator submits expansion plans
October 27, 2003Medicines regulator the EMEA has asked the European Union for a subsidy increase of nearly 13% to pay for its …
Bayer denies Lipobay cover-up
October 27, 2003Bayer has refuted allegations that it concealed serious side-effects of its statin Lipobay before it was withdrawn in July 2001.US …
Pfizer picks US research ‘hotspot’ for trials centre
October 27, 2003Pfizer is to build a new $35 million clinical research centre in an R&D 'hotspot' in New Haven, Connecticut.Due to …
Abbott surprised by early Humira approval
October 27, 2003Abbott Laboratories says US approval of its rheumatoid arthritis product Humira has come earlier than expected, and will now increase …
ClinPhone signals European expansion
October 27, 2003UK clinical trials technology company ClinPhone is to develop its European business to serve clusters of pharmaceutical and biotech companies …
GSK faces growing opposition to US parallel trade policy
October 27, 2003GlaxoSmithKline is facing growing opposition from US patient groups and politicians to its attempt to block cheap drug imports from …
Milburn shortlists 50 hospitals for foundation status
October 27, 2003Health Secretary Alan Milburn has shortlisted 50 hospitals he believes are ready to take on foundation status before the next …
AstraZeneca painkiller collaboration fails
October 27, 2003The future of a potential new blockbuster pain killer under development by AstraZeneca is in doubt after it failed safety …
Lilly and Sankyo to share sales team
October 27, 2003Eli Lilly and Sankyo Pharma UK are to share sales representatives in an innovative new arrangement co-ordinated by contract sales …
NHS promotes primary care drug dictionary
October 27, 2003A campaign to raise PCT awareness of the new Primary Care Drug Dictionary (PCCD) has been launched to promote its …
Canada first market for Crestor
October 27, 2003AstraZeneca's Crestor is to receive an immediate launch in its first market after Canada's regulator's approved the new cholesterol lowering …
Mixed Paxil patent news for GSK
October 27, 2003GlaxoSmithKline has received mixed news in the on-going patent battle with Canadian generics company Apotex over its biggest selling drug, …
Pfizer blockbuster to face competition
October 27, 2003Pfizer's blockbuster hypertension and angina treatment Norvasc could face competition from a related drug following a US court ruling.A ruling …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
